Delivery Order SPE2DB22D2108-SPE2DB25FU5ND
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,401.81 on July 22, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication, with a ceiling value of $46.7K. The contract, which was not set-aside and competitively awarded, carries a firm fixed price structure and an ultimate completion date of August 14, 2025. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, serving as a critical pharmaceutical supply source for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $15,238.68 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of July 24, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The award was processed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,406.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Januvia 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,027.53 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, under which AmerisourceBergen provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $6,429.02. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action supporting federal...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $20,394.12 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Januvia 100 mg tablets. The $3,657.93 firm-fixed-price contract has a performance period through May 30, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5NDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count) with a ceiling value of $6,798.21. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. The contract represents a single pharmaceutical procurement under AmerisourceBergen's existing relationship with the federal government to supply medical commodities to defense and military healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's performance of work is based in Conshohocken, Pennsylvania, its corporate headquarters, and it maintains a demonstrated track record of fulfilling federal medical supply requirements across multiple therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 8/19/25 |